scholarly journals Stereochemical features of the envelope protein Domain III of dengue virus reveals putative antigenic site in the five-fold symmetry axis

2013 ◽  
Vol 1834 (1) ◽  
pp. 221-230 ◽  
Author(s):  
R.O.S. Soares ◽  
A. Caliri
2020 ◽  
Vol 278 ◽  
pp. 197882
Author(s):  
Yongchao Zhou ◽  
Dong Chen ◽  
Lan Yang ◽  
Weiwei Zou ◽  
Zhiliang Duan ◽  
...  

Virulence ◽  
2017 ◽  
Vol 8 (8) ◽  
pp. 1719-1731 ◽  
Author(s):  
Guan-Ling Lin ◽  
Hsin-Hou Chang ◽  
Te-Sheng Lien ◽  
Po-Kong Chen ◽  
Hao Chan ◽  
...  

2008 ◽  
Vol 82 (17) ◽  
pp. 8828-8837 ◽  
Author(s):  
Gregory D. Gromowski ◽  
Nicholas D. Barrett ◽  
Alan D. T. Barrett

ABSTRACT The surface of the mature dengue virus (DENV) particle is covered with 180 envelope (E) proteins arranged as homodimers that lie relatively flat on the virion surface. Each monomer consists of three domains (ED1, ED2, and ED3), of which ED3 contains the critical neutralization determinant(s). In this study, a large panel of DENV-2 recombinant ED3 mutant proteins was used to physically and biologically map the epitopes of five DENV complex-specific monoclonal antibodies (MAbs). All five MAbs recognized a single antigenic site that includes residues K310, I312, P332, L389, and W391. The DENV complex antigenic site was located on an upper lateral surface of ED3 that was distinct but overlapped with a previously described DENV-2 type-specific antigenic site on ED3. The DENV complex-specific MAbs required significantly higher occupancy levels of available ED3 binding sites on the virion, compared to DENV-2 type-specific MAbs, in order to neutralize virus infectivity. Additionally, there was a great deal of variability in the neutralization efficacy of the DENV complex-specific MAbs with representative strains of the four DENVs. Overall, the differences in physical binding and potency of neutralization observed between DENV complex- and type-specific MAbs in this study demonstrate the critical role of the DENV type-specific antibodies in the neutralization of virus infectivity.


Acta Tropica ◽  
2015 ◽  
Vol 142 ◽  
pp. 103-107 ◽  
Author(s):  
Daniel H. Libraty ◽  
Lei Zhang ◽  
AnaMae Obcena ◽  
Job D. Brion ◽  
Rosario Z. Capeding

2007 ◽  
Vol 846 (1-2) ◽  
pp. 184-194 ◽  
Author(s):  
Priyabrata Pattnaik ◽  
J. Pradeep Babu ◽  
Shailendra Kumar Verma ◽  
Vijay Tak ◽  
P.V. Lakshmana Rao

2020 ◽  
Vol 30 (3) ◽  
pp. 199-206
Author(s):  
Sheeza Ali ◽  
Samia Afzal ◽  
Muhammad Zubair Yousaf ◽  
Muhammad Shahid ◽  
Iram Amin ◽  
...  

2016 ◽  
Vol 91 (4-5) ◽  
pp. 497-512 ◽  
Author(s):  
Johanna Gottschamel ◽  
Andreas Lössl ◽  
Stephanie Ruf ◽  
Yanliang Wang ◽  
Morten Skaugen ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Te-Sheng Lien ◽  
Hao Chan ◽  
Der-Shan Sun ◽  
Jhen-Cheng Wu ◽  
You-Yen Lin ◽  
...  

In tropical and subtropical regions, mosquito-borne dengue virus (DENV) infections can lead to severe dengue, also known as dengue hemorrhage fever, which causes bleeding, thrombocytopenia, and blood plasma leakage and increases mortality. Although DENV-induced platelet cell death was linked to disease severity, the role of responsible viral factors and the elicitation mechanism of abnormal platelet activation and cell death remain unclear. DENV and virion-surface envelope protein domain III (EIII), a cellular binding moiety of the virus particle, highly increase during the viremia stage. Our previous report suggested that exposure to such viremia EIII levels can lead to cell death of endothelial cells, neutrophils, and megakaryocytes. Here we found that both DENV and EIII could induce abnormal platelet activation and predominantly necrotic cell death pyroptosis. Blockages of EIII-induced platelet signaling using the competitive inhibitor chondroitin sulfate B or selective Nlrp3 inflammasome inhibitors OLT1177 and Z-WHED-FMK markedly ameliorated DENV- and EIII-induced thrombocytopenia, platelet activation, and cell death. These results suggest that EIII could be considered as a virulence factor of DENV, and that Nlrp3 inflammasome is a feasible target for developing therapeutic approaches against dengue-induced platelet defects.


Sign in / Sign up

Export Citation Format

Share Document